CoreLab Partners has nearly doubled the amount it has collected in its latest round with an updated regulatory filing showing the company raising $8.7m of a planned $11.7m total.
In March, medical imaging company CoreLab Partners, which was created out of the merger of RadPharm and Medifacts International in December, raised $4.7m from 10 investors, according to its regulatory filing.
Although there is no statement, Andrew Jay, managing partner of Siemens Venture Capital, is named as a director of CoreLab. Other investors include venture capital firms Ampersand Ventures and SV Life Sciences, according to news provider Mass High Tech that first noticed the filing.